2021
DOI: 10.3390/ijms22115913
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic Dysfunction in Spinal Muscular Atrophy

Abstract: Spinal muscular atrophy (SMA) is an autosomal recessive genetic disorder leading to paralysis, muscle atrophy, and death. Significant advances in antisense oligonucleotide treatment and gene therapy have made it possible for SMA patients to benefit from improvements in many aspects of the once devastating natural history of the disease. How the depletion of survival motor neuron (SMN) protein, the product of the gene implicated in the disease, leads to the consequent pathogenic changes remains unresolved. Over… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
25
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 27 publications
(28 citation statements)
references
References 258 publications
3
25
0
Order By: Relevance
“…The cell division pathway and axon guidance genes were significantly downregulated in the P5 spinal cord, which was not observed in the P4, indicating that SMA pathogenesis undergoes great physiopathological changes from the middle stage to the late stage [ 22 ]. Most of the down-regulated pathways in the P4 spinal cord are metabolically related, consistent with the widespread metabolic dysregulation observed in SMA that has been demonstrated [ 66 ].…”
Section: Discussionsupporting
confidence: 78%
“…The cell division pathway and axon guidance genes were significantly downregulated in the P5 spinal cord, which was not observed in the P4, indicating that SMA pathogenesis undergoes great physiopathological changes from the middle stage to the late stage [ 22 ]. Most of the down-regulated pathways in the P4 spinal cord are metabolically related, consistent with the widespread metabolic dysregulation observed in SMA that has been demonstrated [ 66 ].…”
Section: Discussionsupporting
confidence: 78%
“…Spinal muscular atrophy (SMA) affects lower motor neurons and is caused by mutations to the gene survival motor neuron 1. In SMA, there is widespread metabolic dysfunction, impacting glucose, amino acid, and lipid metabolism [168]. In a mouse model of SMA where a drug treatment was paired with nutritional support, SMA mice had increased survival and enhanced skeletal muscle innervation.…”
Section: Other Motor Neuron Diseasesmentioning
confidence: 99%
“…The cell division pathway and axon guidance genes were significantly downregulated in the P5 spinal cord, which was not observed in the P4, indicating that SMA pathogenesis undergoes great physiopathological changes from the middle stage to the late stage [22]. Most of the down-regulated pathways in the P4 spinal cord are metabolically related, consistent with the widespread metabolic dysregulation of SMA that has been demonstrated [64].…”
Section: Discussionmentioning
confidence: 74%